1 / 4

Standard vs High-dose Clopidogrel after PCI: GRAVITAS

Standard vs High-dose Clopidogrel after PCI: GRAVITAS.

geraldine-aguirre
Télécharger la présentation

Standard vs High-dose Clopidogrel after PCI: GRAVITAS

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Standard vs High-dose Clopidogrelafter PCI: GRAVITAS Objective: to evaluate high-dose with standard dose clopidogrel in patients with high on-treatmentplateletreactivity (≥230 PRU) after PCI Study: multicenterrandomized double-blind trialPopulation: patients with PCI with 1 or more DES for stable CAD or non-STEMI Endpoint: MACE: cardiacdeath, MI, stentthrombosisat 6 monthsSafety: severe or moderatebleeding (GUSTO definition)

  2. Standard vs High-dose Clopidogrelafter PCI: GRAVITAS

  3. Standard vs High-dose Clopidogrelafter PCI: GRAVITAS

  4. Standard vs High-dose Clopidogrelafter PCI: GRAVITAS Conclusion high-dose clopidogreldoes not reduce incidence of MACE or bleedingcompared to standard dose in patients with high on-treatmentreactivity Price JAMA 2011;305:1097-1105

More Related